Adia Nutrition Expands Rapidly, Tripling Sales Force with Regional Teams to Fuel U.S. and Worldwide Growth
Winter Park, Florida--(Newsfile Corp. - September 9, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine, is excited to announce a rapid expansion of its sales operations by tripling its sales force and creating four specialized teams to accelerate growth and market reach for its innovative Adialabs products. This strategic restructuring divides sales operations into dedicated teams for the East Coast, West Coast, Central U.S., and a team focused on nationa
Healthcare and Hospitals, Health
2025-09-09 8:30 AM EDT | Adia Nutrition Inc.
Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology
White Bear Lake, Minnesota--(Newsfile Corp. - September 9, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the issuance of four new global patents. These patents expand the company's global intellectual property portfolio and mark another strategic step in delivering next-generation cochlear implant solutions that offer patients discreet, 24/7 hearing experience wit
Biotechnology, Healthcare and Hospitals
2025-09-09 8:00 AM EDT | Envoy Medical, Inc.
Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025
White Bear Lake, Minnesota--(Newsfile Corp. - September 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced today announced that Brent Lucas, Envoy Medical's Chief Executive Officer, will present virtually at the H.C. Wainwright 27th Annual Global Investment Conference, which is being held September 8-10, 2025 in New York City. Mr. Lucas' presentation is now av
Biotechnology, Healthcare and Hospitals
2025-09-08 8:00 AM EDT | Envoy Medical, Inc.
Adia Nutrition Inc. Identifies Over 20 Million Potentially Improperly Issued Shares and Initiates Process to Return Shares to Treasury
Winter Park, Florida--(Newsfile Corp. - September 4, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on advancing stem cell therapies for orthopedics, pain management, wound repair, and regenerative medicine, today announced that it has identified over 20 million shares that may have been improperly issued as part of an ongoing review of its historical share structure. This discovery comes from a comprehensive internal audit designed to strengthen the integr
Healthcare and Hospitals, Health
2025-09-04 8:45 AM EDT | Adia Nutrition Inc.
Discovery Senior Living Showcases Bespoke Lifestyle at the Watermark at Brooklyn Heights with Pet-Centered Living
Bonita Springs, Florida--(Newsfile Corp. - September 3, 2025) - Discovery Senior Living ("Discovery" or the "Company"), one of the largest and most trusted operators of senior housing in the U.S., is pleased to highlight one of its unique pet-centered lifestyle initiatives at The Watermark at Brooklyn Heights, underscoring the Company's ability to create highly bespoke living environments tailored to local markets.
Healthcare and Hospitals, Real Estate, Housing
2025-09-03 4:38 PM EDT | Discovery Senior Living
Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant
White Bear Lake, Minnesota--(Newsfile Corp. - September 3, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted technologies, today announced that the patients in the first stage of its pivotal clinical trial for the investigational Acclaim® fully implanted cochlear implant have successfully reached their three-month follow-up milestone. During this timeframe, no serious adverse events (SAEs) or unan
Biotechnology, Healthcare and Hospitals
2025-09-03 8:00 AM EDT | Envoy Medical, Inc.
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
King of Prussia, Pennsylvania--(Newsfile Corp. - September 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL® siRNA gene silencing technology to eliminate cancer. Phio today announced th
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-09-03 7:45 AM EDT | Phio Pharmaceuticals Corp.
Scryb Reports Financial Results for Q3 2025: Positive Outlook for Cybeats Technologies Corp.
Toronto, Ontario--(Newsfile Corp. - September 3, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb'' or the "Company") has filed financial results for its third quarter ended June 30, 2025 ("Q3 2025"), and also provides commentary on Scryb's largest holding, Cybeats, which filed its second quarter ended June 30, 2025 Interim Financial Statements and Management's Discussion and Analysis ("MD&A"). Scryb's reported results for Q3 2025 reflect the transition to equity accounting for C
Biotechnology, Healthcare and Hospitals, Health
2025-09-03 7:20 AM EDT | Scryb Inc.